NCT07474103 2026-03-16
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase NA Recruiting
Clinical Trials
21 trialsNCT05838391 2026-02-03
Adaptive Radiation in Anal Cancer
Columbia University
Phase NA Recruiting
NCT07334587 2026-01-12
Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma
Allama Iqbal Medical College
Phase NA Enrolling by invitation
NCT07156058 2025-09-04
MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Recruiting
NCT04894643 2025-05-08
PARC
EBG MedAustron GmbH
Phase NA Recruiting
NCT06894797 2025-03-25
Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT04281576 2024-11-14
Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma
NovoCure Ltd.
Phase NA Completed
NCT06349044 2024-08-27
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
Zhejiang Cancer Hospital
Phase NA Recruiting
NCT02528175 2023-12-07
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer
Sunnybrook Health Sciences Centre
Phase NA Completed
NCT05877573 2023-07-05
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Nanfang Hospital, Southern Medical University
Phase NA Recruiting
NCT01280643 2021-03-15
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Fox Chase Cancer Center
Phase NA Terminated
NCT03634202 2019-05-15
DESIR
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT02358863 2018-09-06
mEGA
Georgetown University
Phase NA Terminated
NCT00763516 2017-09-06
PC02
University of Florida
Phase NA Completed
NCT00685763 2017-08-24
PC01
University of Florida
Phase NA Completed
NCT03042000 2017-02-03
Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
Peking Union Medical College Hospital
Phase NA Unknown
NCT00176735 2015-05-20
Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
University of Michigan Rogel Cancer Center
Phase NA Terminated
NCT00159471 2014-05-22
Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.
University of Southern California
Phase NA Terminated
NCT02043821 2014-01-24
Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker
Beijing Chao Yang Hospital
Phase NA Unknown
NCT00524069 2013-02-01
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Roswell Park Cancer Institute
Phase NA Withdrawn
NCT01549795 2012-07-18
Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Azienda Ospedaliera di Padova
Phase NA Unknown